Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145177 | SCV000192226 | pathogenic | Microcephaly 5, primary, autosomal recessive | 2013-12-05 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000790789 | SCV000345866 | pathogenic | not provided | 2016-09-20 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000790789 | SCV001502569 | pathogenic | not provided | 2020-12-01 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000145177 | SCV002019899 | pathogenic | Microcephaly 5, primary, autosomal recessive | 2021-01-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000145177 | SCV002787127 | likely pathogenic | Microcephaly 5, primary, autosomal recessive | 2021-10-12 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000145177 | SCV004178589 | likely pathogenic | Microcephaly 5, primary, autosomal recessive | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Johns Hopkins Genomics, |
RCV000145177 | SCV004239052 | pathogenic | Microcephaly 5, primary, autosomal recessive | 2023-11-15 | criteria provided, single submitter | clinical testing | This ASPM variant (rs587783263 ) is rare (<0.1%) in a large population dataset (gnomAD v4.0.0: 4/1461022 total alleles; 0.0003%; no homozygotes). It has been reported in ClinVar (Variation ID 157864), but has not been reported in the literature in individuals known to be affected with microcephaly and having biallelic ASPM variants, to our knowledge. This frameshift variant results in a premature stop codon in exon 18 of 28, likely leading to nonsense-mediated decay and lack of protein production. We consider c.7125_7128dup in ASPM to be pathogenic. |
Gene |
RCV000790789 | SCV005443035 | pathogenic | not provided | 2024-07-02 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31980526, 31069529) |
Labcorp Genetics |
RCV000790789 | SCV005722351 | pathogenic | not provided | 2024-11-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln2377Thrfs*26) in the ASPM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ASPM are known to be pathogenic (PMID: 19028728, 23611254). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with microcephaly (PMID: 31069529). ClinVar contains an entry for this variant (Variation ID: 157864). For these reasons, this variant has been classified as Pathogenic. |